Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology
Inge M.W. Verberk(Amsterdam Neuroscience), Charlotte E. Teunissen(Amsterdam Neuroscience), Philip Scheltens(Amsterdam University Medical Centers), Wiesje M. van der Flier(Amsterdam Neuroscience), Erik Stoops(ADx NeuroSciences), Sander C.J. Verfaillie(Amsterdam UMC Location VUmc), Arno de Wilde(University of Geneva), Jeroen Vanbrabant(ADx NeuroSciences), Bart N.M. van Berckel(Amsterdam Neuroscience), Hugo Vanderstichele(ADx NeuroSciences), Elisabeth H. Thijssen(Amsterdam Neuroscience), Frederik Barkhof(National Hospital for Neurology and Neurosurgery), Jannet Koelewijn(Amsterdam Neuroscience), Rik Ossenkoppele(Malmö University), Marissa D. Zwan(Amsterdam UMC Location VUmc), Kimberley Mauroo(ADx NeuroSciences)
Cited by 274
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Consistent resting-state networks across healthy subjects
|Proceedings of the National Academy of Sciences|2006|4.4k